Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brian Costello, MD is an oncologist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Connecticut, and Tennessee. He is affiliated with Mayo Clinic - Rochester and is an Assistant Professor at Mayo Medical School.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2009
Medical College of WisconsinClass of 2000
University of New Mexico School of MedicineResidency, Internal Medicine, 1995 - 1998- Medical College of WisconsinClass of 1995
Certifications & Licensure
NH State Medical License 2013 - Present
ND State Medical License 2014 - 2028
MT State Medical License 2014 - 2028
AZ State Medical License 2013 - 2028
WI State Medical License 2013 - 2027
MN State Medical License 1998 - 2027
MI State Medical License 2013 - 2026
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014-2017
Publications & Presentations
PubMed
- 9 citationsGenomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients.Surendra Dasari, Michael R McCarthy, Antonina A Wojcik, Beth A Pitel, Arpan Samaddar
Prostate Cancer and Prostatic Diseases. 2025-06-01 - 2 citationsRenal Cell Carcinoma With Venous Tumor Thrombus Has a Predilection for the Lungs.Reza Nabavizadeh, Rodrigo Rodrigues Pessoa, John C Cheville, Christine M Lohse, Brian A Costello
Urology. 2025-04-01 - 13 citationsRandomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, David J Kwiatkowski, Shiven Patel
Lung Cancer. 2024-09-01
Authored Content
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in PatientsMay 2020
- Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in PatientsMay 2020
